openPR Logo
Press release

BPH Devices Market is Expected to Observe an Absolute Growth of over 242% by 2025 – Arizton

Changing lifestyle is considered as an important factor contributing to the increasing demand for BPH devices in the market.

According to the latest Arizton's market research report, the benign prostatic hyperplasia devices size to cross USD 800 million by 2020, growing at a CAGR of 22% during the forecast period.

Benign Prostatic Hyperplasia Devices - Market Growth

Changing lifestyle is considered as an important factor contributing to the increasing demand for BPH devices in the market. The rising prevalence of benign prostatic hyperplasia is the primary factor driving the growth of BPH devices. Vendors are focusing on technological advancement to develop and commercialize innovative and advanced BPH treatment. The growth in developed countries is driven due to the introduction of safety legislation and increasing patient population that requires advanced BPH treatment for quick recovery. The rising prevalence of geriatric men is eventually increasing the patient population driving the global BPH devices market.

Get your free sample now! https://www.arizton.com/market-reports/benign-prostatic-hyperplasia-devices-market

Growing Popularity of Robotic-Assistance Surgical Techniques for BPH

Robot-assisted surgery for BPH treatment is innovative and trending among the end-users mostly in the developed countries. The innovative surgeries offer benefits for both patients and surgeons that have been helping to treat diseases over the past few decades. The demand for robotic surgery is becoming popular with the rapid technological advancements. Robot-assisted surgery is a minimally invasive surgery approach which integrates advanced computer technology. This strategy adopted by companies is expected to provide access to treatments in affordable prices and will gain traction in upcoming years across the globe. Robotic surgery expanded the benefits of minimally invasive surgery by offering wide dexterity, and maneuverability over conventional surgical devices.

Key Offerings:
• Market Size & Forecast by Revenue | 2019−2025
• Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
• Segmentation – A detailed analysis by procedure, end-users, and geography
• Competitive Landscape – 5 Key Company Profiles and 14 Other Prominent Vendors

Get your free sample now! https://www.arizton.com/market-reports/benign-prostatic-hyperplasia-devices-market

Benign Prostatic Hyperplasia Devices – Geographic Analysis

APAC market accounted for the largest share in the BPH market globally. Japan is the leading revenue contributor in the APAC BPH devices market. The demand for UroLift is relatively higher in Japan compared to other APAC countries. The growth of the market in APAC is driven by the factors such as growth in economy, the living standard of people is also increasing attributed to the increase in per capita income, and the prevalence of various acute and chronic diseases. North America is growing at a fast CAGR due to the growing preference for technologically advanced BPH devices. The high cost of BPH devices can affect the market adversely and the presence of reimbursement coverage for both invasive and minimally invasive treatment options will have a positive impact on the growth. The availability of reimbursement coverage for several BPH devices is likely to boost the market in the region.

Competition Overview

The global BPH devices market is concentrated and characterized by the presence of established vendors holding majority of the market share. Vendors especially, global players are pursuing inorganic growth strategies such as acquisitions and strategic partnership to expand their presence, enhancing product portfolios, and improving expertise in the market. There is a significant number of global as well as regional players offering advanced BPH devices globally. Teleflex, KARL STORZ, Lumenis, Urologix, and Boston Scientific are the key players in the BPH devices market. These companies have a wide geographic footprint, diversified product portfolio, and a strong focus on innovation and research activities.

Looking for more information? Click Here https://www.arizton.com/market-reports/benign-prostatic-hyperplasia-devices-market

About Arizton Advisory & Intelligence

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize fool proof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including –Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Arizton Advisory & Intelligence
Chicago, Illinois, 60605
Mail: enquiry@arizton.com
Call: +1-312-235-2040/+1 302 469 0707

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release BPH Devices Market is Expected to Observe an Absolute Growth of over 242% by 2025 – Arizton here

News-ID: 2252372 • Views:

More Releases for BPH

Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.
BPH Surgical Treatment Market worth $17.19 billion in 2030
Browse 368 market data Tables and 59 Figures spread through 328 Pages and in-depth TOC on "BPH Surgical Treatment Market by Type (TURP, Laser, Rezum, Urolift, Ablation, PAE), Drug Type (Alpha Blocker (Alfuzosin), Alpha Reductase Inhibitor (Dutastride), Therapy (Mono, Combination), End Users (Hospitals) - Global Forecast to 2030 The global [https://www.marketsandmarkets.com/Market-Reports/benign-prostatic-hyperplasia-treatment-market-198000374.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=benignprostatichyperplasiasurgicaltreatmentmarket], valued at US$11.92 billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, reaching US$12.62 billion in
Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment M …
How Big Is the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been robust growth in the market size of benign prostatic hyperplasia (BPH) treatment devices and equipment. The market, which stood at $1.29 billion in 2024, is anticipated to increase to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%.
Benign Prostatic Hyperplasia (BPH) Treatment Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Benign Prostatic Hyperplasia (BPH) Treatment Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. The benign prostatic hyperplasia (BPH) treatment market is experiencing significant growth due to the rising prevalence of BPH among the aging male
How big is Benign Prostate Hyperplasia (BPH) Market?
Benign Prostate Hyperplasia (BPH) Market is forecasted to reach at a CAGR of 6% during the forecast period (2024-2031). The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Benign Prostate Hyperplasia (BPH) market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market
Laser BPH Devices Market Expected to Reach $765.4 Million by 2031
Laser BPH devices market was valued at $460.25 million in 2021, and is estimated to reach $765.4 million by 2031, growing at a CAGR of 5.2% from 2022 to 2031. Prostate enlargement, commonly known as benign prostatic hyperplasia (BPH), is a noncancerous expansion of the prostate gland. Frequent urination, difficulty starting to urinate, a weak stream, the inability to urinate, or a loss of bladder control are examples of symptoms.